Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 overexpression as a prognostic indicator in endometrial carcinoma.

European journal of gynaecological oncology - 1 Jan 2003

Ozalp S, Yalcin O T, Tanir H Mete, Kabukcuoglu S, Erol G

Abstract excerpt

PURPOSE: To investigate the prognostic value of p53 overexpression in endometrial adenocarcinoma cases of different stages and histologic subtypes. METHODS: One hundred and eleven surgically staged endometrial carcinoma (EC) cases from 1996 to 2000 constituted this retrospective study group. Prognostic factors determined through the evaluation of surgery specimens by co-author pathologist, were surgical stage,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Biopsy, Needle
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Neoplasm Staging

Share to Probability

Share to Proportional Hazards Models

Share to Survival Analysis

Source

Identifiers

PMID: 12807239

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 overexpression as a prognostic indicator in endometrial carcinoma.PMID 12807239Read ↗

p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review.Semantic proximity Read ↗

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.Semantic proximity Read ↗

Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison.Semantic proximity Read ↗

p53 oncoprotein as a prognostic indicator in patients with breast cancer.Semantic proximity Read ↗

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.Semantic proximity Read ↗

The prognostic significance of the triple negative phenotype in endometrial cancer.Semantic proximity Read ↗

Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancerSemantic proximity Read ↗

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility.Semantic proximity Read ↗

p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis.Semantic proximity Read ↗

A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancer.Semantic proximity Read ↗

Relation between p53 overexpression and established prognostic factors in breast cancer.Semantic proximity Read ↗

Polymorphism of p53 gene codon 72 in endometrial cancer: correlation with tumor grade and histological type.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.